Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation
β Scribed by Yokoyama, Kazunari K.; Kawasaki, Hiroaki; Eckner, Richard; Yao, Tso-Pang; Taira, Kazunari; Chiu, Robert; Livingston, David M.
- Book ID
- 109732152
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 477 KB
- Volume
- 393
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/30538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract F9 embryonal carcinoma cells differentiate in response to retinoic acid (RA). To investigate the regulation of RA receptors (RARs) expression during this process, cDNA probes specific for the major RAR isoforms were used. In contrast to the level of RARΞ²2 mRNA which was high in cells tr
## Abstract Transcription factors Octβ3/4 and Sox2 behave as global regulators during mammalian embryogenesis. They work together by binding coβoperatively to closely spaced __HMG__ and __POU__ motifs (__HMG__/__POU__ cassettes). Recently, it was suggested that a critical Sox2:Octβ3/4 target gene,
Mouse F9 embryonic teratocarcinoma stem cells can be induced to differentiate into visceral endoderm. Following retinoic acid (RA) treatment, alpha-fetoprotein (AFP), a differentiation marker, is expressed and secreted. The mechanism by which RA regulates AFP expression during differentiation is not
Several differentiation-specific genes, including those for collagen IV and laminin, are induced by retinoic acid IRA) in mouse F9 teratocarcinoma cells. Dibutyryl CAMP can enhance the effect of RA in these cells, but dibutyryl CAMP alone does not induce these genes. Inhibition of RNA synthesis with